Takeda Pharmaceutical Co Ltd (NYSE:TAK)

17.71
Delayed Data
As of 4:00pm ET
 +0.47 / +2.73%
Today’s Change
12.43
Today|||52-Week Range
20.00
-2.69%
Year-to-Date
Amicus' (FOLD) Q4 Earnings Miss Estimates, Sales Beat on Galafold
Mar 02 / Zacks.com - Paid Partner Content
The Top New Buys of Larry Robbins' Firm
Feb 26 / GuruFocus News - Paid Partner Content
Denali's (DNLI) Q4 Earnings & Revenues Beat on Biogen Deal
Mar 01 / Zacks.com - Paid Partner Content
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
Feb 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close17.24
Today’s open17.67
Day’s range17.53 - 17.79
Volume5,169,356
Average volume (3 months)2,869,777
Market cap$52.3B
Data as of 4:00pm ET, 03/03/2021

Growth & Valuation

Earnings growth (last year)-74.46%
Earnings growth (this year)+341.99%
Earnings growth (next 5 years)+16.80%
Revenue growth (last year)+60.06%
P/E ratio33.0
Price/Sales1.57
Price/Book1.19

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-3.46-1.63%
----
REGNRegeneron Pharmaceut...-8.25-1.81%
----
Data as of 7:20pm ET, 03/03/2021

Financials

Next reporting dateMay 11, 2021
EPS forecast (this quarter)$0.33
Annual revenue (last year)$30.3B
Annual profit (last year)$406.9M
Net profit margin1.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Osaka, Osaka

Forecasts